Authors:
KAMINUMA T
SHIMIZU H
AHMAD I
OCHIAI N
EHAMA R
OHNUMA M
BANBA T
WATABE K
LERNER EA
IMAIZUMI S
TAJIMA M
YOSHIMOTO T
Citation: T. Kaminuma et al., PREVENTION OF CEREBRAL VASOSPASM BY VASODILATORY PEPTIDE MAXADILAN FOLLOWING SUBARACHNOID HEMORRHAGE IN RABBITS, Journal of controlled release, 52(1-2), 1998, pp. 71-80
Authors:
LEE PK
SUGERMAN PB
QURESHI AA
KOCHEVAR IE
LERNER EA
Citation: Pk. Lee et al., ULTRAVIOLET-B STIMULATES NITRIC-OXIDE PRODUCTION IN HUMAN KERATINOCYTES, Journal of investigative dermatology, 110(4), 1998, pp. 553-553
Authors:
LEE PK
SUGERMAN PB
OURESHI AA
LERNER LH
LERNER EA
Citation: Pk. Lee et al., NITRIC-OXIDE PRODUCTION AND DIFFERENTIAL CELLULAR-LOCALIZATION OF NITRIC-OXIDE SYNTHASES IN HUMAN KERATINOCYTES, Journal of investigative dermatology, 110(4), 1998, pp. 554-554
Citation: Rl. Osullivan et al., THE NEURO-IMMUNO-CUTANEOUS-ENDOCRINE NETWORK - RELATIONSHIP OF MIND AND SKIN, Archives of dermatology, 134(11), 1998, pp. 1431-1435
Citation: O. Moro et Ea. Lerner, MAXADILAN, THE VASODILATOR FROM SAND FLIES, IS A SPECIFIC PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE TYPE-I RECEPTOR AGONIST, The Journal of biological chemistry, 272(2), 1997, pp. 966-970
Citation: Lh. Lerner et al., COEXISTENCE OF CUTANEOUS AND PRESUMPTIVE PULMONARY ALTERNARIOSIS, International journal of dermatology, 36(4), 1997, pp. 285-288
Citation: O. Moro et al., RECEPTORS FOR THE VASODILATOR MAXADILAN ARE EXPRESSED ON SELECTED NEURAL CREST AND SMOOTH MUSCLE-DERIVED CELLS, Insect biochemistry and molecular biology, 26(10), 1996, pp. 1019-1025
Authors:
YOSHIDA S
TAKAMATSU T
DENDA S
OHNUMA M
TAJIMA M
LERNER EA
KANDA F
Citation: S. Yoshida et al., STRUCTURAL CHARACTERIZATION AND LOCATION OF DISULFIDE LINKAGES OF A POTENT VASODILATORY PEPTIDE, RECOMBINANT MAXADILAN, BY A MULTIPLE MASS-SPECTROMETRIC APPROACH, Rapid communications in mass spectrometry, 10(6), 1996, pp. 641-648
Authors:
QURESHI AA
HOSOI J
XU S
TAKASHIMA A
GRANSTEIN RD
LERNER EA
Citation: Aa. Qureshi et al., LANGERHANS CELLS EXPRESS INDUCIBLE NITRIC-OXIDE SYNTHASE AND PRODUCE NITRIC-OXIDE, Journal of investigative dermatology, 107(6), 1996, pp. 815-821
Authors:
TORJI H
HOSOI J
MORO O
LERNER EA
XU S
TAKASHIMA A
GRANSTEIN RD
Citation: H. Torji et al., LANGERHANS CELLS AND NERVES - FURTHER SUPPORT FOR A FUNCTIONAL-RELATIONSHIP, Journal of investigative dermatology, 106(4), 1996, pp. 110-110
Authors:
MORO O
OHNUMA M
WAKITA K
TAJIMA M
LERNER EA
Citation: O. Moro et al., RECEPTORS FOR THE CUTANEOUS VASODILATOR MAXADILAN ARE PRESENT IN BRAIN AND NEURO-DERIVED CELL-LINES, Journal of investigative dermatology, 106(4), 1996, pp. 178-178
Citation: Aa. Oureshi et al., LANGERHANS CELLS PRODUCE NITRIC-OXIDE, A TOXIN FOR MELANOCYTES, Journal of investigative dermatology, 106(4), 1996, pp. 454-454
Citation: Aa. Oureshi et al., EXPRESSION OF ADRENERGIC-RECEPTORS ON LANGERHANS CELLS SUGGESTS A ROLE FOR STRESS IN SKIN-DISEASE, Journal of investigative dermatology, 106(4), 1996, pp. 455-455
Citation: Ym. Bello et al., MELANOPHORES EXPRESS THE RECEPTOR FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE, Journal of investigative dermatology, 106(4), 1996, pp. 478-478
Citation: Ym. Bello et al., PARTIAL CHARACTERIZATIONS OF A GROWTH-FACTOR FOR XENOPUS MELANOPHORES, Journal of investigative dermatology, 106(4), 1996, pp. 630-630
Authors:
QURESHI AA
ASAHINA A
OHNUMA M
TAJIMA M
GRANSTEIN RD
LERNER EA
Citation: Aa. Qureshi et al., IMMUNOMODULATORY PROPERTIES OF MAXADILAN, THE VASODILATOR PEPTIDE FROM SAND FLY SALIVARY-GLAND EXTRACTS, The American journal of tropical medicine and hygiene, 54(6), 1996, pp. 665-671
Authors:
ASAHINA A
MORO O
HOSOI J
LERNER EA
XU S
TAKASHIMA A
GRANSTEIN RD
Citation: A. Asahina et al., SPECIFIC INDUCTION OF CAMP IN LANGERHANS CELLS BY CALCITONIN-GENE-RELATED PEPTIDE - RELEVANCE TO FUNCTIONAL-EFFECTS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8323-8327
Authors:
GREVELINK SA
OSBORNE J
LOSCALZO J
LERNER EA
Citation: Sa. Grevelink et al., VASORELAXANT AND 2ND-MESSENGER EFFECTS OF MAXADILAN, The Journal of pharmacology and experimental therapeutics, 272(1), 1995, pp. 33-37